Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

AMDHD1 acts as a tumor suppressor and contributes to activation of TGF-β signaling pathway in cholangiocarcinoma

14 Aug 2024

Abstract excerpt

Cholangiocarcinoma (CCA) is a malignant tumor of the digestive system, characterized by its aggressive behavior and the absence of effective therapeutic biomarkers. Although recent studies have implicated AMDHD1 in tumor formation, its role in CCA development has been insufficiently explored. We utilized multiple bioinformatic datasets alongside 108 clinical samples to examine AMDHD1 expression in CCA. Then, in...

Topics

Join the communities discussing this publication.

Cholangiocarcinoma and Gallbladder Cancer Studies
Pancreatic and Hepatic Oncology Research
TGF-β signaling in diseases

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 39143229
DOI: 10.1038/s41418-024-01361-y

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

AMDHD1 acts as a tumor suppressor and contributes to activation of TGF-β signaling pathway in cholangiocarcinomaPMID 39143229Read ↗

Genetic, Epigenetic, and Microenvironmental Drivers of Cholangiocarcinoma.Semantic proximity Read ↗

Comprehensive analysis of DNA methylation and gene expression profiles in cholangiocarcinomaSemantic proximity Read ↗

The Role of microRNAs in CholangiocarcinomaSemantic proximity Read ↗

YTHDF1 promotes intrahepatic cholangiocarcinoma progression via regulating EGFR mRNA translationSemantic proximity Read ↗

Genomic characterization and immunotherapy for microsatellite instability-high in cholangiocarcinoma.Semantic proximity Read ↗

Epigenetic silencing of tumor suppressor gene CDKN1A by oncogenic long non-coding RNA SNHG1 in cholangiocarcinomaSemantic proximity Read ↗

Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles.Semantic proximity Read ↗

CYB5D2 inhibits the malignant progression of hepatocellular carcinoma by inhibiting TGF-β expression and epithelial-mesenchymal transitionSemantic proximity Read ↗

Cholangiocarcinoma: molecular pathways and therapeutic opportunities.Semantic proximity Read ↗

Identification and Validation of lncRNA-Related Prognostic Signatures in CholangiocarcinomaSemantic proximity Read ↗

miR-28-5p inhibits cholangiocarcinoma progression and predicts good prognosis of patientsSemantic proximity Read ↗

JUND/linc00976 promotes cholangiocarcinoma progression and metastasis, inhibits ferroptosis by regulating the miR-3202/GPX4 axisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.